CEO & President, Brainsway; IATI Co-Chair (Life Science)
The excellent academic research in the biomed field in Israel, and its interplay with Israel’s entrepreneurial spirit and top tier engineering abilities, are a tremendous source of potential in this field in Israel. Over the years these factors have been supported by government policy. The combination of MNC R&D centers, with increased private support and investments from Israeli and foreign sources, will grow the biomed industry in a way that will enable companies to develop and flourish in Israel and generate a significant increase in employment opportunities in the field.
Co-CEO & President, Pluristem Therapeutics
IATI plays an important role in the growth and flourish of the Israeli life science industry - bio-pharma, medical device, digital health and more. IATI is the focal point of all levels of the eco-system - academia, industry, investors, regulators, service providers and others, all find relevant channels to share best practices and make a change, through IATI's committees and work groups.
IATI is working closely with the government as the voice of the industry, adjusting current policies within the Israeli authorities though a dialogue, and new exciting projects come to life thanks to long term co-work of IATI with government and municipalities. We are seeing more international stock exchanges, funds, and global organizations working closely with IATI, so that they have access to the Israeli market and companies, approaching the local Israeli technologies and talents. IATI's MIXiii-BIOMED Conference is one of the most important conferences in the world for the life science industry and it is an important meeting point between Israeli and global life science industry, researchers, entrepreneurs, VCs and service providers, presenting and discussing the most innovative breakthrough and medical trends.
I work with IATI for over half a decade now, IATI helps in connecting the Israeli high-tech industry and the ultra-Orthodox (Haredi) sector. Organized a special tour in Bnei Brak for the High-tech executives and leaders, provided mentoring for Haredi start-up entrepreneurs, exposed the subject in their conferences and soon we will launch a dedicated forum. In addition I cooperate with IATI in project aims to encourage girls to study science and technology.
Outgoing General Manager, Microsoft Israel R&D Center
I find the IATI MNC Forum, the first and only of its kind, to be an effective forum to meet and get to know our colleagues – the managers of multinational R&D centers in Israel, to expand our knowledge of best practices, and to promote interests that are common to MNC R&D centers in Israel.
With common goals, experiences and challenges, the IATI MNC Forum has provided a platform in which everyone mutually benefits through open communication and networking. As a unified group working together, with a substantial presence in the Israel hi-tech scene, we are able to strengthen the Israeli ecosystem as well as encourage the growth of existing R&D centers in Israel and the establishment of new ones. The IATI tirelessly continues to play a crucial role in the organization, promotion and logistics of all forum meetings and events with utmost professionalism.
CEO, Tel Aviv Stock Exchange
The partnership between the Tel Aviv Stock Exchange (TASE) and IATI is rooted in common goals and aspirations. Both our organizations strive to cultivate hi-tech companies and assist their development into globally competitive enterprises, to the benefit of the Israeli economy and society. Working together, IATI and TASE generate a self-reinforcing dynamic of business development, in which TASE serves as the natural venue for taking Israeli tech enterprises public. This synergy from this partnership mutually benefits both the Israeli tech industries and the local capital market as well as the communities in which both operate and serve.
CEO, The Israel Innovation Authority
The strength of the life science industry in Israel lies in its competitive advantage. Consisting of long-standing scientific excellence in the field of biopharma, unique medical and genomic sources of information, leadership in ICT, computing and AI technologies, an advanced healthcare system and government initiatives aimed at encouraging synergy between information technologies and life sciences. This unique combination presents opportunities for Israeli companies to make breakthrough developments and take leadership positions in the global life science industry
IATI has been an important pillar of the Israeli high tech. As a non-for-profit group, representing the tech eco-system in Israel, IATI has been promoting important agendas towards elevating further the strength and the importance of this industry.
We at Leumitech have been proudly working with IATI on several project, each of which perusing the important purpose to enable and provide added-value to the industry with regards to further education specifically on the financing angel, for technology companies, at various stages of their life cycle.
Each in our own field of expertise, both Leumitech and IATI view themselves as essential part of all aspects of the industry and we look forward to the next opportunity to continue working to encourage and strengthen the growth of the Israeli eco-system.
Prof. Varda Shalev
Managing Director - Morris Kahn & Maccabi Research and Innovation Institue
IATI shows great commitment to promoting the evolving field of digital health. As a leading medical organization, we work together with IATI on finding new ways to do just that.
Founder and Partner, Magma Venture Partners
IATI is an organization that is unlike any other in the world; it’s a holistic approach that includes and integrates all contributors to the tech ecosystem: startups, multinationals with R&D centers, university research centers, incubators, accelerators, advisors (such as legal and accounting firms), and the investment community. It empowers the ecosystem by encouraging members to work together to build and strengthen our industry, and it is unique in that it enables companies that are seemingly competitors to collaborate on projects. Its main objective is to assist entrepreneurs and other stakeholders to build strong, successful global leaders through its programs.
I’m proud to be a longtime member of the board, and I strongly believe that this forum provides members invaluable and exciting business opportunities.
General Partner, Canaan Partners
We have been active members of the IATI since its inception. Actually, we have helped manage the transition from a small association, which represented the interests of the venture capital community in Israel, to what the IATI is today: an organization that covers all aspects of the Israeli advanced technologies industries. Being part of this impressive community helps Canaan Partners accomplish its business goal in Israel: connect with entrepreneurs and help them build great companies. IATI provides us with a comprehensive platform for networking, for exchanging innovative ideas with our industry partners and for creating countless business opportunities. The IATI staff, managed by Karin Mayer Rubinstein, is always available for members’ requests, always resourceful and always on top of new initiatives which help promote the organization’s goals further.
VP Business Development, ICB - Israel China Biotechnology Investment
IATI's involvement was highly important while co-organizing with us a large scale event in China. IATI's team efficiently co-selected 40 relevant IATI members as Israeli delegates to China; excellently presented on Israel to Chinese government, investors and tech companies at the event; and easily helped connecting interested Israeli and Chinese organizations. I was deeply impressed by IATI's deep global and local connections and abilities to "tie the ties". I am looking forward to future working with IATI!
CEO, Hadasit Medical Research
We are a member of IATI for many years. IATI is an important vehicle for us to expose our company and technologies to relevant clients. IATI helps in connecting the Israeli academia and hospitals to the industry including startups, multinationals, and the investment community. We use IATI's industry database, and find Israel's life Sciences Industry IATI yearly report important and useful, especially with our international partners.
We would like to thank IATI's staff and hope to continue our relationship in the future
Dr. Yaron Danieli
President & CEO, Yissum - The Technology Transfer Company of The Hebrew University of Jerusalem
Entrepreneurial spirit and deep biomedical expertise converge in Israel to create a massive nexus of innovations. Through rounds of trial and error, experienced leadership and business development skills enabled some of these innovations to reach the market and transform into truly cutting-edge therapies and products. Limited resources still prevent many new groundbreaking technologies to be fully tested and validated, presenting unique investment opportunities to those with a healthy appetite for early-stage technologies and a deeply imaginative vision of the future of Healthcare.
Dr. Ami Appelbaum
Chairman Israel Innovation Authority and Chief Scientist, Ministry of Economy and Industry
Israel is recognized as an innovation hub. This is due mainly to innovations made in the field of Information and Communication Technologies (ICT). Israel boasts the highest concentration of PHDs per capita and has world leading research institutes.
New and advanced developments of artificial intelligence and big data provide Israel a unique foothold for the Israeli life science industry. Creating breakthrough solutions and products to serve as a strong growth engine for the Israeli industry and economy as well as transform the entire life science industry both on a local and global perspective.
Prof. Ronni Gamzu
CEO, Tel Aviv Sourasky Medical Center
The strength of the life science industry in Israel originates both from the strive for knowledge and scholarship and the dynamic spirit of innovation and entrepreneurship. All along conjoint with a startup ecosystem and proper public and private capital backbone. This is a propelling force for the Israeli economy and we must continue to put efforts to flourish it further.
Dr. Laurence Keselbrener
Site leader and VP R&D, Medtronic
The strength of the life science industry in Israel lies in its innovative culture joined to strong academic and scientific foundations. We need to continue investing in funding early stage innovative companies but not lose sight of the large and medium multi-national companies’ impact on the Israeli ecosystem. The multinational companies with R&D and production centers fuels the sustainable growth of our industry and will allow expanding the high tech employees proportion in Israel.
Dr. Shlomo Markel
Vice President, Broadcom
IATI and its team initiate activities and creative execution, via networking and communication, thus enabling further enhancement of the Israeli Advanced Technology Industries ecosystem. As for multinational companies, IATI's work helps them to share and promote common interests, as well as to encourage growth and establish new players.
Managing Partner, Takwin Labs
IATI is invaluable to any start up company in Israel, regardless of its stage. They provide an endless array of offerings to the managers of the company; introductions to industry players and investors; shared knowledge base; seminars and courses; professional committees etc. Above all, the team of IATI, though it handles multi-national corporations and all the leading entities in the market, treats start-up companies as top priority and cultivates this space as one of its primary goals.
Co-Founder & Board Member, EarlySense
The strength of the life science industry in Israel lies in the comradery of entrepreneurs. In any stage of a company, an executive in Israel will have access to leaders in more advanced stages or with more experience that will help in networking, fundraising, FDA strategy etc. The lessons learned are handed over within the ecosystem making it smarter and more efficient.
Dr. Anat Cohen-Dayag
President & CEO, Compugen
Scientific excellence and an entrepreneurial spirit are two of the major strengths of the Israeli life sciences industry, and what make Israel an attractive innovation center. With this infrastructure we now need to build life science product development capabilities to facilitate the transition from early-stage product opportunities to a more advanced product development industry, leading toward a sustainable biotech model.
CEO, Ramot at Tel Aviv University
I have been involved with IATI and the leadership team in the last 12 months. I find them committed to the significant challenges and opportunities surrounding both the high-tech and biotech industry in Israel, setting up clear vision for the new organization and taking multiple initiatives to set meanings into the vision.
I find the execution team, led by Karin, extremely active and creative as well as receptive to feedback for improvements. Considering the short time the newly structured organization is operating I am very optimistic with our ability to make an impact.
Founder & Chief Business Officer, MindSpace
Hosting IATI related industry events have shown to bare great results for us: first, by attracting even more relevant, young tech companies to our facilities; and second, by creating new diverse traffic through the deep IATI network.
As a leading coworking space, it's a great experience for us to take part in this intersection of the local ecosystem which IATI conducts and enables.
Prof. Zeev Rotstein
CEO, Hadassah Medical centers
The strength of the life science industry in Israel lies in its human assets. The industry is driven by highly talented, scientifically and academically oriented researchers, whose excellence and innovative thought processes attract equally talented business and industry visionaries. This symbiosis generates remarkable opportunities and achievements. It is therefore of great importance to encourage the nation's youth to engage in higher education and for government to support higher education. The cerebral mass of all of the country's researchers must be regarded as a national natural resource.
Michal Rosen Zvi
Director for Healthcare Informatics, IBM Research
Israel is a global leader in innovation and development of Artificial Intelligence technologies. The vibrant healthtech ecosystem, including life Science and Medical Devices companies, has started to benefit from this growth engine. I expect AI to make an even bigger impact on the Israeli healthteck in the near future.
CEO, Oramed Pharmaceuticals
The strength of the Israeli life science Industry lies in our ability to rapidly bring concepts into the clinic with rapid turnaround times for prototypes. Our ability to constantly translate the amazing academic works done here in Israel into solutions for the whole world gives us the advantage as an industry.
Dr. Nitza Kardish
CEO of Trendlines Agtech - Mofet
The IATI organization was an active partner in the promotion of our Agrivest 2013 Conference. We would like to express our deep thanks to the IATI team for undertaking and supporting this event from the beginning. I have no doubt that the partnership with IATI contributed much to the success of the conference which attracted overwhelming feedback from both overseas and Israeli participants. We appreciate your support and friendship and look forward to many opportunities to work together in the future.